Month: October 2012

Vigilant Completes Feasibility Clinical Study of New “Rinse and Spit” Test to Aid Clinicians in Early Detection of Oral Cancer October 17, 2012 MIAMI, Florida Vigilant Biosciences, Inc., (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, , today announced the completion of a National Cancer